Evidence map›Paper›PMID 30897114›Full record

ArticlePloS one2019

Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

Jerome Bouquet, Tony Li, Jennifer L Gardy, Xiaoying Kang, Staci Stevens, Jared Stevens, Mark VanNess, Christopher Snell, James Potts, Ruth R Miller and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Recent research in myalgic encephalomyelitis/chronic fatigue syndrome: an evidence map.Health technology assessment (Winchester, England) · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Oxidative stress is a shared characteristic of ME/CFS and Long COVID.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Jerome BouquetDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.
Tony LiDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.
Jennifer L GardyCommunicable Disease Prevention and Control Services, Vancouver, Canada.
Xiaoying KangSchool of Population and Public Health, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-1999-9304
Staci StevensWorkwell Foundation, Ripon, California, United States of America.
Jared StevensWorkwell Foundation, Ripon, California, United States of America.
Mark VanNessWorkwell Foundation, Ripon, California, United States of America.ORCID 0000-0001-5902-8735
Christopher SnellWorkwell Foundation, Ripon, California, United States of America.
James PottsDepartment of Pediatrics, Division of Cardiology, University of British Columbia, Vancouver, Canada.ORCID 0000-0003-2041-7711
Ruth R MillerSchool of Population and Public Health, University of British Columbia, Vancouver, Canada.
Muhammad MorshedBritish Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.
Mark McCabeCommunicable Disease Prevention and Control Services, Vancouver, Canada.
Shoshana ParkerCentre for Health Evaluation Outcome Sciences, Vancouver, Canada.
Miguel UyaguariBritish Columbia Centre for Disease Control Public Health Laboratory, Vancouver, Canada.
Patrick TangDepartment of Pathology, Sidra Medical and Research Center, Doha, Qatar.
Theodore SteinerDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
Wee-Shian ChanDepartment of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, Canada.
Astrid-Marie De SouzaDivision of Cardiology, British Columbia's Children's Hospital, Vancouver, Canada.
Andre MattmanDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
David M PatrickCommunicable Disease Prevention and Control Services, Vancouver, Canada.
Charles Y ChiuDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0003-2915-2094
University of British Columbia · CAUniversity of California, San Francisco · USBC Centre for Disease Control · CABC Children's Hospital · CACentre for Advancing Health Outcomes · CASidra Medical and Research Center · QA

Funding

Exploring Host Gene Expression during Post-Exertional Symptom Flare in ME/CFS: AR21NS088166 · NINDS · UNIVERSITY OF BRITISH COLUMBIA · PI PATRICK, DAVID MICHAEL · 2014 to 2015
$272k
NINDS NIH HHS R21 NS088166
6 · The paper itself

Abstract

Myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) is a syndrome of unknown etiology characterized by profound fatigue exacerbated by physical activity, also known as post-exertional malaise (PEM). Previously, we did not detect evidence of immune dysregulation or virus reactivation outside of PEM periods. Here we sought to determine whether cardiopulmonary exercise stress testing of ME/CFS patients could trigger such changes. ME/CFS patients (n = 14) and matched sedentary controls (n = 11) were subjected to cardiopulmonary exercise on 2 consecutive days and followed up to 7 days post-exercise, and longitudinal whole blood samples analyzed by RNA-seq. Although ME/CFS patients showed significant worsening of symptoms following exercise versus controls, with 8 of 14 ME/CFS patients showing reduced oxygen consumption ([Formula: see text]) on day 2, transcriptome analysis yielded only 6 differentially expressed gene (DEG) candidates when comparing ME/CFS patients to controls across all time points. None of the DEGs were related to immune signaling, and no DEGs were found in ME/CFS patients before and after exercise. Virome composition (P = 0.746 by chi-square test) and number of viral reads (P = 0.098 by paired t-test) were not significantly associated with PEM. These observations do not support transcriptionally-mediated immune cell dysregulation or viral reactivation in ME/CFS patients during symptomatic PEM episodes.

Indexed as

AdultCase-Control StudiesExerciseExercise TestFatigueFatigue Syndrome, ChronicFemaleGene Expression ProfilingHumansLongitudinal StudiesMiddle AgedTranscriptome

Identifiers

PMID30897114
PMCPMC6428308
OpenAlexW2924099879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.